XARC (XtalPi AI Research Center) was established in March 14 of 2016 at Z-Park, Beijing, a long-standing innovation hub for top research institutions, talents, and hi-tech companies. With an office area of about 1500㎡, XARC has recruited a strong team of cross-disciplinary researchers working in areas such as computational science, chemistry, and math. Through close collaboration between its teams of AI algorithm scientists, computational chemists, and computer engineers, XARC has accumulated strong expertise and valuable experience in areas of deep learning, machine learning, data mining, multi-method integration, large-scale cloud computing resource scheduling, and more. XARC is working with top research organizations and pharmaceutical innovators and offering its expertise in AI and machine learning to empower the research of therapeutics, especially in early drug discovery and screening. XARC is committed to driving and empowering drug R&D innovation by effectively combining drug development data and deep learning algorithms. It is using algorithms to helping pharmaceutical companies address the many challenges in the research and development of new drugs and streamlining the computation and prediction processes to reduce the cost, time, and risk of pharmaceutical research.
XtalPi Drug Innovation Research Center is based in Shanghai Simbay Park. Our Drug Innovation Research Center features a 6,000 ㎡ production area and an integrated drug discovery experimentation platform to support our collaboration with global companies in small molecule and biologics drug discovery and chemical synthesis.
Located in the heart of Shanghai Zhangjiang Science City, XtalPi Greater China Business Center is our China commercialization hub. Our Great China Business Center connects XtalPi with our pharmaceutical and biotech partners in the Greater China region and provides technical support to facilitate the commercial adoption of artificial intelligence in innovative drug research and discovery.
Located in Kendall Square, Cambridge, Massachusetts, XtalPi’s overseas Business Center is the company’s first location that opened shortly after it was founded in 2014. The Boston Business Development team are comprised of scientists from MIT, Harvard, Yale University and seasoned campaigners from the pharmaceutical industry, with rich experience in developing drugs from early discovery and moving the molecule along value chain to clinical & commercialization. The R & D centers in Beijing and Shenzhen further provide the technical expertise to test and validate customer challenges. In addition to being a research center for internal projects and external collaborations, the Boston office also serves as a business development center for clients in the US, Europe, and part of Asia. As an innovative company that came out of the MIT campus, XtalPi has always maintained a close relationship with the academic community. XtalPi’s Boston overseas Business Center maintains close communication with professors and experts from research community as well as from the pharmaceutical industry.
In May 2019, XtalPi obtained the ISO27001 certificates issued by UKAS (United Kingdom Accreditation Service) and CNAS (China National Accreditation Service for Conformity Assessment) respectively. ISO27001 is a management system centered on information asset security and business risk management. It is the most widely accepted and applied system certification standard in the field of information security. Obtaining this certificate indicates that the company has established a scientific and effective information security management system to provide users with safe and reliable information services.